Related Experiment Video
Updated: Jan 5, 2026

11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.3K
Preventable adverse drug events: Descriptive epidemiology
Stephanie A Woo1, Amber Cragg2, Maeve E Wickham2,3
1Vancouver General Hospital, Vancouver, British Columbia, Canada.
British Journal of Clinical Pharmacology
|October 22, 2019
Summary
Over 64% of adverse drug events are preventable, particularly in patients with mental health conditions and diabetes. Improving patient instructions and monitoring can reduce these events.
Area of Science:
- Pharmacovigilance
- Patient Safety
- Clinical Pharmacy
Background:
- Adverse drug events (ADEs) pose a significant threat to patient safety.
- Identifying preventable ADEs is crucial for improving healthcare outcomes.
Purpose of the Study:
- To identify preventable adverse drug events (ADEs).
- To determine factors contributing to the development of preventable ADEs.
Main Methods:
- Retrospective chart review of 1,356 ADEs in 1,234 emergency department patients.
- Independent chart review by a clinical pharmacist and physician to assess ADE preventability.
- Multivariable logistic regression to identify patient characteristics and contributing factors.
Main Results:
- 64.1% of ADEs were deemed probably or definitely preventable.
- Patients with mental health diagnoses and diabetes were more likely to experience preventable ADEs.
- Commonly implicated medications included warfarin, hydrochlorothiazide, furosemide, insulin, and aspirin; key contributing factors were inadequate patient instructions, monitoring, and follow-up.
Conclusions:
- Patients with mental health conditions and diabetes require enhanced monitoring for ADEs.
- Addressing inadequate patient instructions, monitoring, and follow-up is essential to reduce preventable ADEs.
Related Concept Videos
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Dosing: Geriatric Patients
193
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
193
Pharmacokinetics: Drug–Drug Interactions
309
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
309
Dosage Regimens: Designs and Approaches
226
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
226
Dosage Regimens: Partial Pharmacokinetic Parameters
130
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
130

